[go: up one dir, main page]

BR0314911A - Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal - Google Patents

Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal

Info

Publication number
BR0314911A
BR0314911A BR0314911-0A BR0314911A BR0314911A BR 0314911 A BR0314911 A BR 0314911A BR 0314911 A BR0314911 A BR 0314911A BR 0314911 A BR0314911 A BR 0314911A
Authority
BR
Brazil
Prior art keywords
virus infection
dengue virus
infection inhibitor
monoclonal antibody
hex
Prior art date
Application number
BR0314911-0A
Other languages
English (en)
Inventor
Yasuo Suzuki
Iipal Jwa
Original Assignee
Japan Science & Tech Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science & Tech Agency filed Critical Japan Science & Tech Agency
Publication of BR0314911A publication Critical patent/BR0314911A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"INIBIDOR DE INFECçãO POR VìRUS DA DENGUE E COMPOSTO MONOCLONAL". A presente invenção compreende um inibidor de infecção pelo vírus da dengue, na forma de uma droga que efetivamente inibe a infecção do vírus da dengue, que é caracterizada por conter, como o ingrediente ativo, pelo menos uma molécula de carboidrato tendo como um constituinte essencial um oligossacarídeo representado pela seguinte fórmula: Hex¬ 1¬NAc<225>1-3Hex¬ 2¬<225>1-4Hex¬ 1¬<225>1- (I) (onde Hex¬ 1¬ e HeX¬ 2¬ representam uma hexose).
BR0314911-0A 2002-10-22 2003-10-22 Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal BR0314911A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002307232 2002-10-22
PCT/JP2003/013486 WO2004037272A1 (ja) 2002-10-22 2003-10-22 デング熱ウィルス感染阻害剤

Publications (1)

Publication Number Publication Date
BR0314911A true BR0314911A (pt) 2005-09-27

Family

ID=32170933

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314911-0A BR0314911A (pt) 2002-10-22 2003-10-22 Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal

Country Status (7)

Country Link
US (1) US20060104985A1 (pt)
EP (1) EP1563840A1 (pt)
JP (1) JPWO2004037272A1 (pt)
CN (1) CN1705488A (pt)
BR (1) BR0314911A (pt)
MX (1) MXPA05004379A (pt)
WO (1) WO2004037272A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102123706B (zh) 2008-06-17 2013-08-14 米纳斯吉拉斯联合大学 血小板活化因子受体在治疗黄病毒科病毒引起的感染中的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPH0725689B2 (ja) * 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
EP0316764B1 (en) * 1987-11-20 1994-06-08 Abbott Laboratories Detection of tumor-associated markers in biological fluids
JPH0687061B2 (ja) * 1988-04-12 1994-11-02 ダイナボット株式会社 糖転移酵素活性の免疫学的測定方法
JPH03115863A (ja) * 1990-09-10 1991-05-16 Dainabotsuto Kk 免疫学的測定法による糖脂質の定量方法
US6197568B1 (en) * 1997-07-29 2001-03-06 The Regents Of The University Of Michigan Method and compositions for isolation, diagnosis and treatment of polyanion-binding microorganisms

Also Published As

Publication number Publication date
EP1563840A1 (en) 2005-08-17
CN1705488A (zh) 2005-12-07
WO2004037272A1 (ja) 2004-05-06
MXPA05004379A (es) 2005-11-23
JPWO2004037272A1 (ja) 2006-02-23
US20060104985A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
BR0307356A (pt) Misturas inseticidas sinergìsticas
PE20040972A1 (es) Intermedio de formulacion aceptablemente no higroscopico que comprende un farmaco higroscopico
BR0307575A (pt) Derivados de sulfonila como inibidores de histona desacetilase
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
RU2009126767A (ru) Производное 1-фенил-1-тио-d-глюцитола
BRPI0514536A (pt) uso de oligossacarìdeos não-digerìveis e sacarìdeo de galactose digerìvel, e, composição adequada para o tratamento e/ou prevenção de infecções do trato respiratório e/ou doença de infecção do trato respiratório
BRPI0415449A (pt) combinações de compostos ativos fungicidas sinergìsticos
BRPI0207215B8 (pt) Derivados de pirazolopirimidinona tendo ação de inibição de pde7
AR072329A2 (es) Composicion farmaceutica que comprende nateglinida
UY29007A1 (es) Derivados de 2-carbamida-4-feniltiazol, su preparacinn, y su aplicacinn en terapcutica
BRPI0311323B8 (pt) composto inibidor de c-aril glicosídeo sglt2, composição farmacêutica e combinação
AR067030A2 (es) Composiciones farmaceuticas
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
ES2196527T3 (es) Derivados de 11,15-o-dialquilprostaglandina e, su procedimiento de produccion y medicamentos que incluyen estos como principio activo.
UY29157A1 (es) Composiciones de amitraz
EA200800303A1 (ru) Применение производных и аналогов тиазола при нарушениях, вызванных свободными жирными кислотами
BR0308613A (pt) Combinação de compostos orgânicos
CY1119188T1 (el) Αντιμικροβιακα συντηρητικα για την επιτευξη φαρμακοτεχνικης μορφης πολλαπλης δοσης χρησιμοποιωντας βητα-κυκλοεξτρινες για υγρες μορφες δοσολογιας
ATE485049T1 (de) Physiologisch aktive zusammensetzung gegen diabetes
BR0212075A (pt) Combinações de substâncias ativas fungicidas
DK1483246T3 (da) 5-Substituerede alkylaminopyrazolderivater som pesticider
BR0315139A (pt) Agentes antibacterianos de tetraidroquinolina tricìclica
BR0312768A (pt) Compostos de 5-ariltetrazol, composições do mesmo e usos dos mesmos
CO5560555A2 (es) Cristales de derivado de hidroxinorefedrina
BR0312921A (pt) Composição compreendendo inibidor de reductase hmg-coa

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE 5A., 6A. E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.